(Q38247488)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25204470%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

review article

1 reference

title

Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25204470%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25204470%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Laurence Fardet

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25204470%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

publication date

1 October 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25204470%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25204470%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25204470%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

issue

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25204470%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

1731-1745

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25204470%20AND%20SRC:MED&resulttype=core&format=json

Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years

16 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Prevalence of oral glucocorticoid usage in the United States: a general population perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

[Description of oral glucocorticoid prescriptions in general population].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

The effects of glucocorticoids on adipose tissue lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Adipogenic and lipolytic effects of chronic glucocorticoid exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Pathophysiology of dyslipidemia in Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Glucocorticoids, metabolism and metabolic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Metabolic Syndrome in Cushing’s Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Pathways regulated by glucocorticoids in omental and subcutaneous human adipose tissues: a microarray study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Glucocorticoids down-regulate glucose uptake capacity and insulin-signaling proteins in omental but not subcutaneous human adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Human but not mouse adipogenesis is critically dependent on LMO3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Glucocorticoids inhibit the transcriptional response of the uncoupling protein-1 gene to adrenergic stimulation in a brown adipose cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

The glucocorticoid contribution to obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Minireview: glucocorticoids--food intake, abdominal obesity, and wealthy nations in 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Chronic stress and comfort foods: self-medication and abdominal obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Incidence and risk factors for corticosteroid-induced lipodystrophy: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Differential effects of short-term prednisolone treatment on peripheral and abdominal subcutaneous thickness in children assessed by ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Impact of glucocorticoid-induced adverse events on adherence in patients receiving long-term systemic glucocorticoid therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Corticosteroid-induced lipodystrophy is associated with features of the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Risk of cardiovascular events in people prescribed glucocorticoids with iatrogenic Cushing's syndrome: cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Adipokine profile in glucocorticoid-treated patients: baseline plasma leptin level predicts occurrence of lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Digital photography as an operational tool for assessing corticosteroid-induced lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Natural history of corticosteroid-induced lipodystrophy: a prospective follow-up of 37 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Body composition and cardiovascular risk markers after remission of Cushing's disease: a prospective study using whole-body MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Diabetes in Cushing syndrome: basic and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Pathophysiology of Diabetes Mellitus in Cushing’s Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Effects of glucocorticoids on hepatic sensitivity to insulin and glucagon in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Effects of glucocorticoids and exercise on pancreatic β-cell function and diabetes development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Quantitative analysis of pancreatic glucokinase gene expression in cultured beta cells by competitive polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Serum- and glucocorticoid-inducible kinase 1 (SGK1) mediates glucocorticoid-induced inhibition of insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Quantification of the Risk of Corticosteroid-induced Diabetes Mellitus Among the Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Risk of diabetes associated with prescribed glucocorticoids in a large population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Glucocorticoids and the risk for initiation of hypoglycemic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Incidence and risk factors of steroid-induced diabetes in patients with respiratory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Predicting the occurrence of diabetes mellitus in recipients of heart transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Posttransplant diabetes in kidney transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Short-term tolerance of pulse methylprednisolone therapy in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Glucocorticoid treatment and impaired mood, memory and metabolism in people with diabetes: the Edinburgh Type 2 Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Screening for diabetes in patients with inflammatory rheumatological disease administered long-term prednisolone: a cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Inhaled Corticosteroids and the Risks of Diabetes Onset and Progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Risk factors and incidence of posttransplant diabetes mellitus in Mexican kidney recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Continuous monitoring of circadian glycemic patterns in patients receiving prednisolone for COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Twenty-four-hour profiles of plasma glucose, insulin, C-peptide and free fatty acid in subjects with varying degrees of glucose tolerance following short-term, medium-dose prednisone (20 mg/day) treatment: evidence for differing effects on insulin s

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Efficacy of glimepiride for the treatment of diabetes occurring during glucocorticoid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Glucagon-like peptide-1 receptor agonist treatment prevents glucocorticoid-induced glucose intolerance and islet-cell dysfunction in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

The glucocorticoid receptor controls hepatic dyslipidemia through Hes1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

A transgenic model of visceral obesity and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Obesity and corticosteroids: 11beta-hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Hyperlipidaemia in asthmatic patients receiving long-term steroid therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Corticosteroid treatment, serum lipids and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Glucocorticoid use and serum lipid levels in US adults: the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Effects of short-term glucocorticoids on cardiovascular biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Effect of short-term, low-dose corticosteroids on plasma lipoprotein lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Prospective short-term effects of glucocorticoid treatment on glucose and lipid metabolism in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Diagnosis and complications of Cushing's syndrome: a consensus statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Management of Dyslipidemia in Cushing’s Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Evidence That High Dose Cortisol-Induced Na+Retention in Man Is not Mediated by the Mineralocorticoid Receptor*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Short-term effect of dietary-sodium intake on arterial blood pressure of patients treated with systemic corticosteroids: a prospective, randomised, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

A critical role for vascular smooth muscle in acute glucocorticoid-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Glucocorticoid-induced hypertension: from mouse to man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Glucocorticoid-dependent hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Hypertension and other morbidities with Cushing's syndrome associated with corticosteroids: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

How do glucocorticoids cause hypertension: role of nitric oxide deficiency, oxidative stress, and eicosanoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Glucocorticoid-induced hypertension in the elderly relation to serum calcium and family history of essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Forgotten but not gone: the rediscovery of fatty heart, the most common unrecognized disease in America

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Coagulopathy in Cushing's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Dual role for glucocorticoids in cardiomyocyte hypertrophy and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Use of oral corticosteroids and the risk of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Mechanisms involved in the side effects of glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Deflazacort. A review of its pharmacological properties and therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

A nonsteroidal glucocorticoid receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

A novel antiinflammatory maintains glucocorticoid efficacy with reduced side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Minireview: new molecular mediators of glucocorticoid receptor activity in metabolic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Glucocorticoid signaling in the arcuate nucleus modulates hepatic insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

A prospective, randomised, placebo-controlled trial of postoperative oral steroid in allergic fungal sinusitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Dexamethasone Induces Posttranslational Degradation of GLUT2 and Inhibition of Insulin Secretion in Isolated Pancreatic β Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Population-based assessment of adverse events associated with long-term glucocorticoid use

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0282-9

Prednisone administration in recent onset type I diabetes

21 January 2018

1 reference

12 December 2020

Evidence that high dose cortisol-induced Na+ retention in man is not mediated by the mineralocorticoid receptor

1 reference

12 December 2020

Corticosteroids and the risk of atrial fibrillation

1 reference

12 December 2020

Losartan in Cushing's syndrome.

1 reference

12 December 2020

Effects of glucocorticoids on energy metabolism and food intake in humans

1 reference

12 December 2020

Gestational diabetes mellitus in women receiving beta-adrenergics and corticosteroids for threatened preterm delivery

1 reference

12 December 2020

The effects of prednisone therapy on plasma lipoproteins and apolipoproteins: a prospective study

1 reference

12 December 2020

A controlled trial of alternate day prednisolone as a maintenance treatment for ulcerative colitis in remission

1 reference

12 December 2020

Risk factors for steroid diabetes in rheumatic patients.

1 reference

12 December 2020

Acute effect of prednisone and deflazacort on glucose tolerance in prediabetic subjects

1 reference

12 December 2020

Altered body fat distribution in patients with glucocorticoid treatment and in patients on long-term dialysis

1 reference

12 December 2020

The glucose-6-phosphatase catalytic subunit gene promoter contains both positive and negative glucocorticoid response elements

1 reference

12 December 2020

The hypertensive effect of synthetic glucocorticoids in man: role of sodium and volume

1 reference

12 December 2020

[Metabolic and cardiovascular adverse events of systemic glucocorticoid therapy]

1 reference

12 December 2020

Hormonal regulation of hormone-sensitive lipase activity and mRNA levels in isolated rat adipocytes

1 reference

12 December 2020

Stimulation of human omental adipose tissue lipolysis by growth hormone plus dexamethasone

1 reference

12 December 2020

Corticosteroids: a review with emphasis on complications of prolonged systemic therapy

1 reference

12 December 2020

The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients

1 reference

12 December 2020

Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing's syndrome

1 reference

12 December 2020

Differentiation of adipose stromal cells: the roles of glucocorticoids and 11beta-hydroxysteroid dehydrogenase

1 reference

12 December 2020

Dexamethasone inhibits insulin-stimulated recruitment of GLUT4 to the cell surface in rat skeletal muscle

1 reference

12 December 2020

Deflazacort vs prednisone. Effect on blood glucose control in insulin-treated diabetics

1 reference

12 December 2020

Glucocorticoid-induced diabetes mellitus: prevalence and risk factors in primary renal diseases

1 reference

12 December 2020

Divided dosing reduces prednisolone-induced hyperglycaemia and glycaemic variability: a randomized trial after kidney transplantation

1 reference

12 December 2020

Some Characteristics of Steroid Diabetes: A Study in Renal-Transplant Recipients Receiving High-Dose Corticosteroid Therapy

1 reference

12 December 2020

A longterm prospective study of the equipotency between deflazacort and prednisolone in the treatment of patients with polymyalgia rheumatica

1 reference

12 December 2020

Dose-response relationships and mineralocorticoid activity in cortisol-induced hypertension in humans.

1 reference

12 December 2020

Exercise prevents cardiometabolic alterations induced by chronic use of glucocorticoids

1 reference

12 December 2020

Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study

1 reference

12 December 2020

Long term (five or more years) administration of corticosteroids in pulmonary diseases

1 reference

12 December 2020

Steroid hormone receptors in human adipose tissues

1 reference

12 December 2020

Trandolapril in Cushing's disease: short-term trandolapril treatment in patients with Cushing's disease and essential hypertension

1 reference

12 December 2020

Differential regulation of beta 1- and beta 2-adrenergic receptor protein and mRNA levels by glucocorticoids during 3T3-F442A adipose differentiation

1 reference

12 December 2020

High incidence of post-transplant diabetes mellitus in a single-centre study

1 reference

12 December 2020

Corticosteroid-induced clinical adverse events: frequency, risk factors and patient's opinion

1 reference

12 December 2020

Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo

1 reference

12 December 2020

Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy

1 reference

12 December 2020

Glucocorticoids and insulin: reciprocal signals for energy balance

1 reference

12 December 2020